As part of the response to the humanitarian crisis in Sudan Sadagaat in a consortium led by Habib Alrahman Charity Foundation (HACF), and Direct Relief and SAPA collectively provided anti-rejection medication *mycophenolate* for kidney transplant patients at a total cost of 131,045 USD.
Sadagaat contributed $50,000 ($30,000 Sadagaat-USA and $20,000 Sadagaat-Canada), Direct Relief $50,000, Sudanese American Physicians Association (SAPA) $25,000
HACF is the leading organization responsible for purchasing, shipping and financial coordination, plus their contribution to the total fund.
Sadagaat-Sudan was responsible for operational oversight and liaison in Sudan.
650,000 tablets of mycophenolate 500mg (enough for 6 months) were received in Port Sudan by the National Medicines Supplies Fund (NMSF) and are being distributed to registered transplant patients of the Sudanese National Kidney Diseases Centre across accessible areas.